Werewolf Therapeutics, Inc.

HOWL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$16,370-$17,982-$18,089-$20,400
Dep. & Amort.$402$406$426$442
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1,793$2,006$1,908
Change in WC$60-$75-$432$458
Other Non-Cash$752$694-$2,859$3,340
Operating Cash Flow-$15,156-$15,164-$18,948-$14,252
Investing Activities
PP&E Inv.$0$0$0-$123
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$123
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$388$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3,274$0$0$2,547
Financing Cash Flow$3,274$388$0$2,547
Forex Effect$0$0$0$0
Net Chg. in Cash-$11,882-$14,776-$18,948-$11,828
Supplemental Information
Beg. Cash$78,491$93,267$112,215$124,043
End Cash$66,609$78,491$93,267$112,215
Free Cash Flow-$15,156-$15,164-$18,948-$14,375
Werewolf Therapeutics, Inc. (HOWL) Financial Statements & Key Stats | AlphaPilot